In the News.. FDA approves new T1D islet cell therapy, what’s next for weight loss and T2D drugs, Dexcom and Libre updates and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: FDA approval for a pancreatic islet cell therapy to treat type 1, stem cell research moves ahead, big news from the ADA Scientific Sessions about what’s next for medications like Mounjaro and a…

The iLet bionic pancreas system - a black insulin pump, tubing and a Dexcom sensor

What does it mean to “Go Bionic?” – A deep dive into the newly-approved iLet system

The newly FDA-approved iLet Bionic Pancreas is the most hands-off automated insulin delivery system to be commercially available. At set up, all you enter is your weight and the only interaction with the pump is to announce meal size, no carb counting. Stacey talks with Beta Bionics CEO Sean Saint. We go through this pump…

A photo of all the components of the Medtronic MiniMed 780G system - infusion set, pump, sensor, phone and watch

The MiniMed 780G – A deep dive into Medtronic’s most advanced system

This long-awaited Medtronic 780G is now FDA approved. It’s been out for two years in Europe and has features that are a bit different from other commercially available automated insulin delivery systems in the US, including a target range down to 100. This week you’ll hear from Heather Lackey, global medical education director for Medtronic…

A package of purple PIP lancers is placed into a blue zippered pouch

A better lancet in the age of CGM? Why PIP’s CEO Josh Pittman says sticks still matter

When many diabetes tech companies are turning their attention to CGMs or closed loop systems, Josh Pittman has his eye on the basics: lancets. His company PIP, makes a new kind of smaller and thinner device for fingersticks. This week, we talk about why he thinks this is still necessary, why he’s passionate about helping…